It is not approved or intended for human or animal use, ingestion, dosing, or therapeutic application
Development of predictive biomarkers and improved formulations would also advance clinical applications
Long-Term Safety Data and Research Long-term safety data in humans remain limited
These injections are typically administered intramuscularly , although some protocols allow for MIC B12 injections to be administered subcutaneously or intramuscularly , depending on clinical preference
Repeated freeze-thaw cycles should be avoided, as they can degrade the peptide and reduce potency
These observations align with improved peripheral blood flow from nitric oxide-mediated vasodilation, though they could also reflect placebo effects or confirmation bias